Antibody Drug Conjugates Services Antibody-drug conjugates Antibody-drug conjugates (ADCs) are a very important class of highly potent drugs designed as.

Slides:

Advertisements

Similar presentations

Antibody-Drug Conjugates (ADCs)

Advertisements

Radioimmunotherapy Allison Spencer July 27, 2006.

THE GENETIC OF CANCER Increased mitosisTumor formation Tumor suppression gene Hyperactive growth TranslocationPoint mutationAmplification Normal growth.

GROUP 5 Monoclonal Antibodies for Cancer Treatment.

HISTORY OF MEDICAL BIOTECHNOLOGY CHANGES IN THE LAST 15 YEARS.

MONOCLONAL ANTIBODIES

Page 1 Cell launched Four Cancer Immunotherapy Featured Reviews By Creative BioMartCreative BioMart.

Dr. Ziad W Jaradat Cancer Stem Cells. Recently biologically distinct and relatively rare populations of tumor-initiating cells have been identified in.

Nanotechnology in Cancer Treatment

Antibody and prodrug therapy of cancer

Review of the Cell Cycle. How big is a cell? Answer.

Gene Therapy Clinical Trials. Cancer Gene Therapy Three Basic Approaches. Genetically alter a person's immune cells that are already naturally targeted.

Progress in Cancer Therapy Following Developments in Biopharma

Page 1 Cell launched Four Cancer Immunotherapy Featured Reviews By Creative BioMartCreative BioMart.

Dr Mahendra Deonarain, Chief Science Officer Antibody Fragment Drug Conjugates (FDCs) Breakthrough ADC therapy BioTrinity April.

NANOTECHNOLOGY IN CANCER TREATMENT

Division of Cancer Treatment and Diagnosis Presented By: Michael Difilippantonio, Ph.D. October 1, 2015.

I am in the Biotechnology industry

DB08870 Brentuximab vedotin C6476H9930N1690O2030S –151.8 kDa.

Novel Transcription Factor Inhibitor as Treatment for Epithelial Cell Cancers John Bushweller, Department of Molecular Physiology and Biological Physics,

Evolution of a “System” for Surgical Treatment of Adenocarcinomas

Small Molecule-DNA Hybrids (SMDHs) for Cancer Therapy

Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors Sara Charmsaz, Andrew M. Scott,

Globular Protein Made of amino acid chains

Action: BM0806 Recent Advances in Histamine Receptor H4R Research

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Chemotherapy and Cancer Stem Cells

Anti-therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer.

Rabbit antibodies Creative Biolabs is a pioneer in recombinant monoclonal antibody development and manufacture. Specifically, we have a wide range of specific.

What is antibody screening While conventional cancer therapies (surgery, chemo therapy, and radiation therapy) have shown some success in the battle again.

Therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer a.

Anti-therapeutic antibodies Creative Biolabs is a pioneer and undisputed global leader in the rapidly emerging market for therapeutic antibodies. We offer.

From Bench to Clinical Applications: Money Talks

by Jennifer Couzin-Frankel

Volume 1, Issue 5, Pages (November 2007)

Engineering Natural Killer Cells for Cancer Immunotherapy

Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma

Nat. Rev. Clin. Oncol. doi: /nrclinonc

Program Introduction. Monoclonal Antibodies and Immunogenicity: Relevance to Clinical Practice?

Schematic diagram of antibody drug conjugate

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Scratching the Surface of Immunotherapeutic Targets in Neuroblastoma

(A) An overview of the JAK/STAT signalling pathway.

Molecular approaches to HER2 targeted therapy

Daniel Abate-Daga, Marco L Davila Molecular Therapy - Oncolytics

Model of the function of TBX2 in RMS.

Figure 2 from Sancho et al.

The cancer stem cell concept in cancer progression and metastasis

The three primary ADC components that determine which cells are targeted (antibody), how the drug is released (linker/trigger), and the mechanism of action.

Sequencing of targeted therapies in HER2-positive metastatic breast cancer Figure 2 from Singh et al. British Journal of Cancer (2014) 111,

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Engineering Natural Killer Cells for Cancer Immunotherapy

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Monoclonal Antibodies

Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors Sara Charmsaz, Andrew M. Scott,

Molecular features of the colon during homeostasis and carcinogenesis

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Kabir A. Khan, Robert S. Kerbel Cancer Cell

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

Figure 1 from D’Incalci et al.

The F-box protein Fbxw7 is required for maintenance of normal stem cells. Figure 1 from S Takeishi British Journal of Cancer (2014) 111, ; doi: /bjc

Nanotechnology in Cancer Treatment

Target antigens for ADCs in solid tumours

Telephone    Provider of Global Contract Research Services Accelerating Preclinical Research, Drug Discovery.

by Jennifer Couzin-Frankel

Possible outcomes of therapeutic treatments using the spiral model.

Human cancer immunotherapy strategies targeting B7-H3 A, blockade of B7-H3 with blocking mAbs neutralizes inhibitory signaling in its unidentified receptor(s)

Presentation transcript:

Antibody Drug Conjugates Services Antibody-drug conjugates Antibody-drug conjugates (ADCs) are a very important class of highly potent drugs designed as a targeted therapy for the treatment of people who has cancer. It represents an innovative therapeutic application that includes the unique, high specificity and antitumor activity of monoclonal antibodies which are tumor-specific but not very cytotoxic, with the cell killing activity of small molecule drugs that are too toxic to be used on their own. Scientists could optimize the features of both components by linking monoclonal antibodies with cytotoxic agents. BOC Sciences is the industry leading expert in small molecular and antibody engineering, also our rich experience could help us to provide comprehensive services for the conjugation and characterization of Antibody-Drug Conjugates. With years of experience in the variety of organic synthesis and binding assays, we provide comprehensive expertise to support the development of antibody-drug conjugate products for all phases of drug development from discovery to GMP manufacturing.antibody-drug conjugate products